Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) appears in 266 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 22,650,988 | 1,513,197 | 7.16% | $215,637,401.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 17,817,012 | 10,412,626 | 140.63% | $169,707,040.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 15,827,186 | 0 | 0.00% | $150,674,811.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Mar, 2026 | 15,038,000 | 697,000 | 4.86% | $143,161,760.00 |
| State Street Corp | 31 Mar, 2026 | 12,208,360 | 1,135,149 | 10.25% | $116,223,587.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 11,244,625 | 11,244,625 | 0.00% | $107,048,830.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 11,135,762 | 11,135,762 | 0.00% | $106,012,454.00 |
| TCG Crossover Management, LLC | 31 Mar, 2026 | 11,020,968 | 11,020,968 | 0.00% | $104,919,615.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 7,434,033 | 4,271,504 | 135.07% | $70,771,994.00 |
| Vestal Point Capital, LP | 31 Mar, 2026 | 7,025,000 | 4,775,000 | 212.22% | $66,878,000.00 |
| TWO SIGMA INVESTMENTS, LP | 31 Mar, 2026 | 6,392,628 | 1,877,311 | 41.58% | $60,857,819.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 5,782,776 | 728,990 | 14.42% | $55,063,276.00 |
| Kynam Capital Management, LP | 31 Mar, 2026 | 5,680,795 | -3,685,731 | -39.35% | $54,081,168.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 5,091,765 | 3,556,208 | 231.59% | $48,473,603.00 |
| Aberdeen Group plc | 31 Mar, 2026 | 5,040,670 | 4,127,077 | 451.74% | $47,987,178.00 |
| UBS Group AG | 31 Mar, 2026 | 4,943,994 | -319,920 | -6.08% | $47,066,823.00 |
| Frazier Life Sciences Management, L.P. | 31 Mar, 2026 | 4,009,240 | 4,009,240 | 0.00% | $38,167,965.00 |
| Royalty Pharma Sub-Manager, LLC | 31 Mar, 2026 | 3,846,154 | 0 | 0.00% | $36,615,386.00 |
| Nuveen, LLC | 31 Mar, 2026 | 3,819,263 | 206,897 | 5.73% | $36,359,384.00 |
| GW&K Investment Management, LLC | 31 Mar, 2026 | 3,240,462 | 79,538 | 2.52% | $30,850.00 |